RxDoctor Payments Data

Kenneth Richards, DO

Family Medicine · Milan, MONPI 1740378785

Payments from drug & device makers

$597in general payments, 2019–2025

Across 27 payments — averaging $22.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$221
  • E.r. Squibb & Sons, L.L.C.$72
  • Teva Pharmaceuticals USA, Inc.$51
  • Mallinckrodt Hospital Products Inc.$51
  • Neurocrine Biosciences, Inc.$50
  • Amgen$50
  • plus $102 from 4 others

What the payments were for

  • Food & beverage$54591%
  • Education$519%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$597 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$7,424
Medicare patients
26
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole113$147,110
Invega SustennaPaliperidone Palmitate42$141,809
Abilify MaintenaAripiprazole32$94,029
AustedoDeutetrabenazine11$53,534
VraylarCariprazine Hcl25$37,108
LamictalLamotrigine12$8,034
Paliperidone ErPaliperidone32$7,654
Effexor XrVenlafaxine Hcl12$6,915
Aripiprazole124$6,590
Hydroxyzine Pamoate158$2,404
Quetiapine Fumarate131$2,163
Bupropion XlBupropion Hcl116$1,900
Doxepin Hcl54$1,785
Prazosin Hcl57$1,586
Buspirone Hcl140$1,450

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$29$241,139145 claims
Johnson & JohnsonInvega Sustenna$221$141,80942 claims
Teva Pharmaceuticals USA, Inc.Austedo$51$53,53411 claims
AbbVieVraylar$23$37,10825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Milan

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →